Old Web
English
Sign In
Acemap
>
Paper
>
Long-Term Safety and Efficacy of Recombinant Human Pentraxin-2 in Patients with Idiopathic Pulmonary Fibrosis
Long-Term Safety and Efficacy of Recombinant Human Pentraxin-2 in Patients with Idiopathic Pulmonary Fibrosis
2019
Ganesh Raghu
B. van den Blink
Mark J. Hamblin
A.W. Brown
Jeffrey A. Golden
Lawrence Ho
Marlies S. Wijsenbeek
Martina Vasakova
Alberto Pesci
Danielle Antin-Ozerkis
Keith C. Meyer
Michael Kreuter
Hugues Santin-Janin
F. Aubin
Geert Jan Mulder
Renu Gupta
Luca Richeldi
Keywords:
Gastroenterology
Internal medicine
Idiopathic pulmonary fibrosis
Medicine
Recombinant DNA
long term safety
in patient
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]